Follow

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Follow
LinkedIN Twitter Instagram Youtube
Contact
LinkedIN Twitter Instagram Youtube

Saudi Arabia approves first Alzheimer’s treatment with lecanemab for early-stage patients

by
July 29, 2025
Saudi Arabia approves first Alzheimer’s treatment with lecanemab for early-stage patients Saudi Arabia approves first Alzheimer’s treatment with lecanemab for early-stage patients

Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has officially approved the registration of lecanemab (Leqembi) for the treatment of patients with early-stage Alzheimer’s disease,

by
Updated
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement

Read more